10:00-10:10 |
Registration |
10:10-10:20 |
Welcome and Congratulatory Remarks |
Duck-Joo Lee Chairman (Council for Advanced Regenerative Medicine) Hyung-woo Ko Director General for Advanced Medical Support (Ministry of Health and Welfare) |
|
|
Moderator : Kyoung-hwan Roh, Executive Director (HLB BioCode) |
|
[Session 1] Evaluation and Analytical Technology Development for Advanced Biopharmaceuticals |
|
Chairperson Sung-yong Won Director of Research Institute (GC Cell) |
|
Chairperson Seung-hee Lee Director of Research (Kangstem Biotech)) |
10:20-10:50 |
Advanced challenges and opportunities for the systemic humanized animal model in the present and near future |
|
Mi-young Choi CEO (C&SR) |
10:50-11:20 |
Organoid-Based Evaluation Technology in Advanced Biopharmaceutical R&D |
|
Jae-young Yoo Division Director (Gradiant Bioconvergence) |
11:20-11:50 |
Holotomography and artificial intelligence: label-free 3D imaging, classification, and inference of live cells, tissues, and organoids |
|
Yong-keun Park Chief Executive Officer (Tomocube) |
11:50-13:20 |
Lunch Time |
[Session 2] 100 Days Until the Implementation of the Revised Advanced Regenerative Bio Act : What Should We Prepare? |
|
Chairperson Chae-ok Yoon Chair of the CARM Policy Committee (GeneMedicine) |
13:20-13:40 |
Keynote Presentation |
|
Mi-Hyun Jung Executive Director (CTX) |
13:40-15:00 |
Panel Discussion |
Mi-Hyun Jung Executive Director (CTX) |
Soon-kil Jung Director (Division of Regenerative Medicine Policy, Ministry of Health and Welfare) |
Min-young Kim Professor (CHA Bundang Medical Center) |
Yeon-sil Yu Director (Kangstem Biotech) |
Ju-hyuk Lee President (Pediatric Rare Incurable Eye Disease Association) |
15:00-15:20 |
Coffee Break |
[Session 3] Current Status of Induced Pluripotent Stem Cell (iPSC) Therapy Development |
|
Chairperson Yu-kyeong Hwang President (CTX) |
|
Chairperson Shin-Jung Lee Executive Director (Karis Bio) |
15:20-15:50 |
Development of iPSC Culture Media Using Customized Cell Media Platform Technology |
|
Joo-youn Lee Head of R&D center, Director (Xcell Therapeutics) |
15:50-16:20 |
Case Studies in iPSC-Based Cell Therapy Development |
|
Sae-bom Lee Senior Researcher (CTX) |
16:20-16:50 |
Considerations for Commercial Production of iPSCs |
|
Ji-hyeon Ju CEO (YiPSCELL) |
16:50-17:00 |
Closing |